OSA is more than sleep—it’s tied to chronic disease, with 80% of patients having multiple comorbidities. Yet, many Home Sleep Apnea Tests (HSAT) may limit use for patients with pacemakers, certain medications, or comorbidities—limiting access to sleep diagnostics.
Nox Medical’s latest Clinical Application Paper: “Inclusive Sleep Testing: Considering Comorbidities in Home Sleep Apnea Testing”, explores the connection between Sleep Disordered Breathing (SDB) and chronic disease, the importance of using HSAT systems without specified contraindications or exclusion criteria, and how the Nox T3 has been utilized in both clinical and research settings to provide comprehensive sleep apnea diagnostics across diverse patient populations, including those with comorbidities.
Key Takeaways from the Clinical Application Paper:
- OSA is highly comorbid with chronic diseases: At least 80% of patients with OSA also have two or more chronic conditions, increasing the complexity of diagnosis and management.
- Traditional HSAT devices may exclude certain patient populations: Some home sleep testing systems restrict use in patients with pacemakers, certain medications, or comorbid conditions, limiting access to diagnostics.
- The Nox T3s is designed for broad clinical use: With no defined contraindications or exclusion criteria in its intended use, the Nox T3s enables comprehensive sleep testing across diverse patient groups, including those with comorbidities.
- Reliable respiratory event detection: Patented dual Nox RIP belts deliver precise measurement of lung volume changes and airflow.
- Clinical research consistently relies on the Nox T3s: A trusted tool in research on cardiovascular disease, COPD, stroke, and more, the Nox T3s delivers high-quality, research-backed diagnostics.
This resource is crafted to help clinicians in navigating the complexities of HSAT device selection, enabling them to make well-informed decisions that prioritize both diagnostic precision and patient care.
Please visit the Clinical Application Paper page to download the resource
Topic: Industry News
